SANTARUS INC. $4.66
http://money.cnn.com/quote/quote.html?symb=SNTS
Shares up double digit percentage and top performer for today. Santarus was featured by Zacks in November as well.
With an FDA approval of an OTC heartburn drug they will add millions to their balance sheet.
This is a company on the move and they should continue to be in the spotlight over the next several months.
More Hot Stocks


